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Synopsis
The relationship between the biological activity of NO and its chemistry is complex. The objectives of this study were to
investigate the influence of oxygen tension on the cytotoxicity of the NO• donor DETA/NO and to determine the effects
of oxygen tension on the key RNS (reactive nitrogen species) responsible for any subsequent toxicity. The findings
presented in this study indicate that the DETA/NO-mediated cytotoxic effects were enhanced under hypoxic conditions.
Further investigations revealed that neither ONOO− (peroxynitrite) nor nitroxyl was generated. Fluorimetric analysis
in the presence of scavengers suggest for the first time that another RNS, dinitrogen trioxide may be responsible for
the cytotoxicity with DETA/NO. Results showed destabilization of HIF (hypoxia inducible factor)-1α and depletion of
GSH levels following the treatment with DETA/NO under hypoxia, which renders cells more susceptible to DETA/NO
cytotoxicity, and could account for another mechanism of DETA/NO cytotoxicity under hypoxia. In addition, there was
significant accumulation of nuclear p53, which showed that p53 itself might be a target for S-nitrosylation following
the treatment with DETA/NO. Both the intrinsic apoptotic pathway and the Fas extrinsic apoptotic pathway were also
activated. Finally, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) is another important S-nitrosylated protein
that may possibly play a key role in DETA/NO-mediated apoptosis and cytotoxicity. Therefore this study elucidates
further mechanisms of DETA/NO mediated cytotoxicity with respect to S-nitrosylation that is emerging as a key player
in the signalling and detection of DETA/NO-modified proteins in the tumour microenvironment.
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INTRODUCTION
NO is a stable-free radical with a relatively short half-life
(seconds) in biological systems [1]. NO• is generated in tissues
by the catalytic action of three main isoforms of NOS (nitric oxide
synthase) enzyme on the amino acid, L-arginine. All three iso-
forms are known to be present in most tumours and are generally
expressed at higher levels in tumours compared with their normal
tissue counterparts [2]. It is well established that NO• plays a key
role in the development, growth and malignant progression of
cancer [3]. It also has a major influence on the response of the
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Abbreviations used: DAF-2DA, 4,5-diaminofluorescein-diacetate; DMEM, Dulbecco’s modified Eagle’s medium; DTT, dithiothreitol; FeTPPs,
5,10,15,20-tetrakis(4-sulfonatophenyl)porphyrinato iron (III); GAPDH, glyceraldehyde-3-phosphate dehydrogenase; GR, glutathione reductase; HIF, hypoxia inducible factor; HNO,
nitroxyl; N2O3, dinitrogen trioxide; NOS, nitric oxide synthase; NOX, NADPH oxidase; O2• − , superoxide; ONOO− , peroxynitrite; RNS, reactive nitrogen species; RSNO, S-nitrosothiols;
SOD, superoxide dismutase; TEMPO-9-AC [4-((9-acridinecarbonyl)amino)-2,2,6,6-tetramethylpiperidin-1-oxyl]; TRAIL, TNF (tumour necrosis factor)-related apoptosis-inducing ligand
1 To whom correspondence should be addressed (email h.mccarthy@qub.ac.uk).
tumour to therapy [4]. NO• delivery by a variety of methods has
been investigated as a potential therapeutic strategy against solid
tumours, using both NO• donor drugs and various gene therapy
strategies to target NO• to cancer cells [5,6]. Anti-tumour efficacy
with minimal normal tissue toxicity has been a consistent feature
of many studies following the systemic administration of NO•
[4]. In biological systems, NO• rapidly reacts with other biolo-
gical components [O2• − (superoxide), O2, thiols and metals] to
form other secondary products that range from harmless meta-
bolites [NO2 − (nitrites) and NO3 − (nitrates)] to the formation
of more toxic related RNS (reactive nitrogen species). There-
fore uncertainty remains around whether NO• contributes to cell
c© 2013 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/
by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited
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cytotoxicity directly or through its RNS. It has been suggested
that the cytotoxic effects of NO• might be attributable to its RNS
[7]. However, the mechanism by which NO• reactive metabolites
exert their cytotoxicity within the tumour microenvironment has
not been completely characterized.
One reaction product, ONOO− (peroxynitrite), has been im-
plicated in numerous pathologies. ONOO− is a product of the
reaction of NO• and O2• − . This reaction occurs quickly be-
cause both NO• and O2• − have valence electrons, so they com-
bine together in a diffusion limited manner to form the oxidant
(Supplementary Scheme S1 at http://www.bioscirep.org/bsr/033/
bsr033e031add.htm Reaction 1). Almost all studies detail that
ONOO− is a potent oxidant and its status has been strongly
linked to various pathological conditions. It is also clearly de-
scribed that ONOO− is formed at significant concentrations in
tumours [8], yet the literature relating to its cytotoxic role in
cancer is limited. Very few studies in cancer highlight this area,
with most related to its role in mutation, inflammation and migra-
tion. There is also clear evidence that ONOO− is an apoptosis
inducer [9]. Another RNS is HNO (nitroxyl), which may be a
product of NOS or could be formed from the decomposition of
RSNO (S-nitrosothiols) [10]. HNO is a potent cytotoxin that me-
diates double-strand DNA breaks via its oxidative intermediates.
Studies using HNO donors have shown that HNO cytotoxicity is
greater than NO• and is comparable with that of H2O2 and al-
kylhydroxyperoxide [11]. NO• could also react with O2 to yield
RNS such as NO2• (Supplementary Scheme S1 Reaction 2) and
N2O3 (dinitrogen trioxide) (Supplementary Scheme S1 Reaction
3). N2O3 generation requires oxidation of NO• first to NO2•
which will then combine with NO• to form N2O3. Although
this reaction is very slow at physiological levels of NO•, it has
been suggested that the accumulation of both NO• and O2 in
hydrophobic areas associated with membranes and proteins may
increase the probability of N2O3 formation [1].
Furthermore, high NO• fluxes under pathological conditions
enable N2O3 formation, which regulates the function of many tar-
get proteins through the coupling of a nitroso moiety (NO+ ) to a
reactive cysteine, ultimately leading to the formation of RSNO, a
process commonly known as S-nitrosylation [12] (Supplement-
ary Scheme S1 Reaction 4). S-Nitrosylation plays an important
part in the NO• physiological process and is considered to be
a post-translational modification that plays a regulatory role in
many protein functions, similar to phosphorylation.
Aberrant S-nitrosylation is associated with the pathogenesis
of wide-ranging diseases, including cardiovascular, pulmonary,
musculoskeletal and neurological disorders, as well as cancer
[13]. The importance of S-nitrosylation in tumours is not fully
understood. S-Nitrosylation of several pro-angiogenic proteins
has been implicated in the progression of cancer such as HIF-1α
(hypoxia-inducible factor 1α), dynamin, Ras and COX2 (cyclo-
oxygenase 2) [14]. Conversely, RSNO have also shown potent
anticancer properties: S-nitrosylated human serum albumin in-
duced apoptosis and inhibited tumour cell growth in vitro and
in vivo [15]. More recently, the anticancer properties of NO•-
NSAIDs (NO•-aspirin and NO•-naproxen) have been attributed
to S-nitrosylation, and have been shown to inhibit human colon
cancer cell growth through suppression of NF-κB (nuclear factor
κB) via S-nitrosylation of the p65 protein [16]. JS-K, a GST
(glutathione transferase)-activated NO• donor has also shown in-
hibition of leukaemia cells via S-nitrosylation and degradation of
nuclear β-catenin [17].
The purpose of this study was to determine the effects of
oxygen tension and the key reactive intermediates of the NO•
donor DETA/NO. In addition, the molecular mechanism of action
and the emerging role of S-nitrosylation induced by DETA/NO
were also investigated.
MATERIALS AND METHODS
Chemicals
DETA/NO 2,2′ -(hydroxynitrosohydrazono) bis-ethanimine
(Sigma) was used in the NO• donor studies. With liberation of
2 moles of NO• per mole of compound and a half-life of 20 h
at 37 ◦C, DETA/NO is ideal for the treatment of cells over a
24 h period. A 10− 3 M stock solution was freshly prepared in
the cell culture medium with subsequent serial dilutions from
10− 3 to 10− 7 M. AS (Angeli’s salt) (Cayman) was used as
HNO donor. It spontaneously dissociates in a pH-dependent,
first-order process with a half-life of 2.3 min at 37 ◦C (pH 7.4).
The salt was reconstituted in 0.1 M NaOH as 0.1 M stock
solution, aliquoted, purged with inert argon gas and stored
at − 80 ◦C. Stock solutions were further diluted with PBS to
prepare the required concentrations and quickly added to the
cells for 10 min at the time of the experiment. Authentic solution
of ONOO− (Calbiochem) was supplied in 4.7 % (w/v) NaOH
(160–200 mM). ONOO− was thawed rapidly, dispensed into
50 μl aliquots, purged with inert argon gas, frozen at − 80 ◦C
and protected from light. For experiments, 50 μl of stock
solutions were thawed and further dilutions in PBS were made
immediately prior to use. To determine the exact concentration,
the absorbance of a 200 μl aliquot of each working solution was
measured at λ= 302 nm (ε = 1670 M− 1 · cm− 1). NaNO2 and
NaNO3 salts (Sigma) were used in NO2 − and NO3 − studies,
respectively. Both NaNO2 and NaNO3 salts were dissolved
in the medium to obtain a range of concentrations which was
consistent with values of NO2 − \ NO3 − accumulated in the
media following 24 h of DETA/NO treatment as determined
by ion selective NO2 − and NO3 − electrodes (Supplement-
ary Figure S1 available at http://www.bioscirep.org/bsr/033/
bsr033e031add.htm). Ebselen, 4-hydroxy-3-methoxyacetop-
henone (Apocynin) and FeTPPs [5,10,15,20-tetrakis(4-
sulfonatophenyl)porphyrinato fer (III)], chloride (Calbiochem)
were used as ONOO− Scavengers. Ebselen and apocynin
were dissolved in DMSO to give a stock solution of 100 and
600 μM, respectively, and stored at − 20 ◦C. Stock solutions of
ebselen and apocynin were further diluted to 10 and 300 μM,
respectively. Control experiments previously confirmed that low
concentrations of DMSO had no significant effect. FeTPPS was
dissolved in distilled water to give a stock solution of 500 μM
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and stored at − 20 ◦C. A stock solution of FeTPPS was further
diluted to 50 μM concentration. Scavengers of RNS particularly
N2O3, which include reduced L-GSH, ascorbic acid and sodium
azide were obtained from Sigma-UK. N2O3 scavengers were
dissolved in PBS, sterilized through a 0.2 μm filter and added to
the cells at 1 mM concentration [18,19]. Scavengers were added
to the cells 2 h before and throughout DETA/NO exposure.
Cell culture
All cells were purchased from the ATCC (American type cul-
ture collection) and were authenticated by the STR (short tan-
dem repeat) profiling carried out by the suppliers. MDA-MB-231
breast cancer cells, DU145 human prostate cancer cells and L132
lung epithelial cells were cultured in DMEM (Dulbecco’s modi-
fied Eagle’s medium), Roswell Park Memorial Institute (RPMI)
1640 and MEM (minimum essential medium), respectively (In-
vitrogen). All media were supplemented with 10 % (v/v) foetal
calf serum and 1 % penicillin–streptomycin (Invitrogen) and cells
were maintained in mono-layers in a tissue culture incubator at
37 ◦C with 5 % (v/v) CO2/95 % (v/v) air and sub-cultured every
3–4 days to maintain exponential growth.
NO• measurement
NO• is ultimately converted into NO2 − and NO3 − , which remain
stable during cell culture and storage at − 20 ◦C. The concentra-
tion of these two end products can be used to quantify NO• release
from DETA/NO without the measurement problems caused by
the transient nature of NO•. NO• levels were determined in the
culture medium using ion-selective electrodes to independently
measure NO2 − and NO3 − (Lazar Research Laboratories) at the
specific time points according to the manufacturer’s instructions.
Clonogenic assay
Cells were seeded in 6-well plates at a density of 200/500 cells
per well for MDA-MB-231 cells and 400/600 cells per well for
DU145 and L132 cells. Seeded plates were incubated at 37 ◦C
with 95 % (v/v) air/5 % (v/v) CO2 for 24 h before DETA/NO ex-
posure. Clonogenic assays were performed under normoxia (21 %
O2) or 0.1 % hypoxia using an Invivo2400 (Ruskinn Technology;
Mid Glamorgan) hypoxic workstation for 24 h post-plating and
before DETA/NO exposure. Following 24 h DETA/NO exposure,
the fresh media were replaced and plates were then incubated for
7–14 days (dependent on the cell line) at 37 ◦C in 5 % CO2/95 %
air and then colonies were fixed and stained with 0.4 % crystal
violet in 70 % (v/v) methanol and counted using an automated
colcount system (Oxford Optronics). 35 mm2 Glass Petri dishes
(Sarstedt) were used for the anoxic experiment to exclude any
oxygen that might be liberated from the plastic dishes [20].
Nuclear extraction
MDA-MB-231, DU145 and L132 cells were seeded in 150 cm2
plates either under normoxia or 0.1 % hypoxia for 24 h post-
plating, followed by treatment with LD50 values of DETA/NO.
Cells were scraped into ice-cold PBS, centrifuged at 4 ◦C for
5 min at 50 g, washed in 1 ml of buffer A [10 mM Tris (pH 7.5),
1.5 mM MgCl2 and 10 mM KCl] freshly supplemented with
1 M DTT (dithiothreitol) and complete protease inhibitor tablets
(Roche), followed by centrifugation at 9.3 g for 10 min at 4 ◦C.
Pellets were resuspended in 0.5 ml of buffer A with 0.1 % Igepal
(Sigma). Cells were kept on ice for 10 min and homogenized.
Nuclei were collected by centrifugation at 16.1 g for 10 min fol-
lowed by resuspension in 0.1 ml of buffer B [0.42 M KCl, 20 mM
Tris (pH 7.5), 20 % (v/v) glycerol, 1.5 mM MgCl2 freshly supple-
mented with 1 M DTT and complete protease inhibitor tablets]
followed by rotation at 4 ◦C for 30 min. The supernatant was
collected following centrifugation for 30 min at 4 ◦C at 29 000 g
and 75 μl buffer C was added [20 mM Tris (pH 7.5), 20 % (v/v)
glycerol, 0.1 M KCl, 0.2 mM EDTA, freshly supplemented with
1 M DTT, and complete protease inhibitor tablets].
Western-blot analysis
MDA-MB-231, DU145 and L132 cells were plated in 35 mm2
dishes and treated with LD50 values of DETA/NO for 24 h either
under normoxic or 0.1 % hypoxic conditions. The cytoplasmic
lysates of cells were collected to determine various pro-apoptotic
proteins, Fas expression and nuclear extracts for HIF-1α, p53
and GAPDH (glyceraldehyde-3-phosphate dehydrogenase). Pro-
tein sample concentration was determined by using the bicin-
choninic acid protein assay kit (Pierce). Each sample (20 μg)
was electrophoresed through a SDS/PAGE (4–12 % gel), trans-
ferred onto a nitrocellulose membrane (Hybond-C) and probed
with the following antibodies [3-nitrotyrosine (Abcam), caspase
3, cleaved caspase 3, caspase 9, cleaved caspase 9, PARP [poly
(ADP ribose) polymerase], cleaved-PARP, p53, Fas, HIF-1α and
GAPDH; Cell Signalling]. Loading controls were either β-actin
(Sigma) for the cytoplasmic lysates or H2B (Cell Signalling)
for the nuclear lysates. Levels of protein expression were as-
sessed using an immobilon Western detection kit (Millipore).
X-ray films were scanned using benchtop UV transilluminators
(UVP Products Ltd) and density was calculated using the imageJ
program (http://rsbweb.nih.gov/ij/) incorporating correction of
loading controls (Figures 3, 9 and 10).
Detection of S-nitrosylated proteins
Total S-nitrosylated proteins were detected in cell lysates follow-
ing the treatment with either LD50 values of DETA/NO, ONOO−
(100 μM) or AS (1 mM) either at normoxic or 0.1 % hypoxic
conditions using a total S-nitrosylated protein kit according to a
modification of Jaffrey et al. [20a] ‘biotin switch’ method (Cay-
man). The principle of the method relies on blocking any SH (free
thiol) groups of proteins followed by cleaving of SNO (nitroso)
group into SH group. SH groups were then labelled by biotin for
the purpose of visualization using streptavidin-HRP (horseradish
peroxidase)-based detection.
Pull down of S-nitrosylated proteins
The biotin switch method was performed on cell lysates follow-
ing a time point treatment with LD50 concentrations of DETA/NO
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either under normoxic or 0.1 % hypoxic conditions. Aliquots of
the protein homogenate were adjusted to achieve equal protein
concentration and stored for Western blotting; the rest of the
sample was processed to purify biotinylated proteins in order to
test the protein of interest with the specific antibodies. Follow-
ing re-suspension of the samples with washing buffer, 2 volumes
of neutralization buffer [20 mM Hepes-NaOH, pH 7.7, 100 mM
NaCl, 1 mM EDTA, 0.5 % (v/v) Triton X-100] were added and
biotinylated proteins were pulled down with 25 μl of packed
streptavidin-agarose (Sigma) per mg protein for 1 h at room tem-
perature (22 ◦C). Beads were then washed three times with neutra-
lization buffer containing 600 mM NaCl, incubated with elu-
tion buffer (20 mM Hepes–NaOH, pH 7.7, 100 mM NaCl,
1 mM EDTA, 100 mM 2-mercaptoethanol) for 20 min at room
temperature. Aliquots from both the total fraction and the 2-
mercaptoethanol eluate were separated by SDS/PAGE, and West-
ern blot analysis was performed.
Determination of the total GSH levels
The total cellular GSH content was determined using a GSH as-
say kit (Cayman). As anticipated, S-nitrosylated GSH, GSNO
(S-nitrosoglutathione), is not a substrate for GR (glutathione re-
ductase) since the reducing thiol is no longer available for the
GR catalysed enzymatic reduction of the reporting substrate [21].
Briefly, MDA-MB-231, DU145 and L132 cells were plated onto
90 cm2 dishes and incubated overnight either at normoxic or 0.1 %
hypoxic conditions for cellular adherence. Cells were treated with
LD50 values of DETA/NO. Following each time point, cells were
washed with ice-cold PBS, and processed according to the man-
ufacturer’s instructions. All data were normalized to 1 mg of
protein.
Fluorescent probes for measurement of N2O3 and
HNO formation
Nitrosylation of cell permeable DAF-2DA (4,5-diaminofluo-
rescein-diacetate) (Sigma) was used as a marker of nitrosative
stress and N2O3 formation as previously shown [22]. MDA-
MB-231, DU145 and L132 cells were plated onto black 96-well
plates and left overnight to adhere. Cells were first loaded with
5 μM of DAF-2DA for 30 min at 37 ◦C, DAF-loaded cells were
washed followed by DETA/NO exposure (0.01 mM, 0.1 mM,
0.5 mM and 1 mM) for a specific time point under normoxia
or 0.1 % hypoxia. Plates were read using a fluorescence plate
reader (FLUOstar OPTIMA; BMG LABTECH) with an excita-
tion wavelength of 485 nm and a detection wavelength of 530 nm.
The contribution of N2O3 to DAF-2DA fluorescence was also per-
formed using DETA/NO +− N2O3 scavengers. Cells were treated
with DETA/NO (0.1 and 1 mM) +− nitrosylation quenchers (GSH,
ascorbate and sodium azide) for 24 h either in normoxia or 0.1 %
hypoxia and fluorescence was measured as mentioned before.
In order to test whether HNO was formed following cellular
exposure to DETA/NO, cells were probed with a pre-fluorescent
probe TEMPO-9-AC [4-((9-acridinecarbonyl)amino)-2,2,6,6-
tetramethylpiperidin-1-oxyl] (Invitrogen), which has previously
been used to detect HNO and to differentiate it from NO• [23]. A
stock solution of TEMPO-9-AC (5 mM) was dissolved in acetoni-
trile, purged with nitrogen, stored as aliquots at − 20 ◦C and pro-
tected from light. Stock solutions were further diluted and used
at 50 μM. MDA-MB-231, DU145 and L132 cells were plated
onto black 96-well plates. After 24 h exposure to DETA/NO at
the LD50 dose, cells were washed twice with PBS and incubated
with 50 μM of TEMPO-9-AC probe. After a 1 h incubation with
the fluoroprobe at 37 ◦C, fluorescence was measured using a plate
reader at a wavelength of 430 nm.
Caspase-8 fluorimetric assay
MDA-MB-231, DU145 and L132 were plated in 90 cm2 dishes
and left overnight for adherence, followed by treatment with
LD50 concentrations of DETA/NO for 24 h either at normoxia
or 0.1 % hypoxia. Caspase 8 activity was assessed by caspase-8
fluorimetric assay kit (R and D systems), which uses a fluori-
genic substrate AFC (7-amino-4-trifluoromethyl coumarin) as an
indicator for caspase 8 enzyme activity.
Statistical analysis
All experiments were a minimum of three independent replicates
with results expressed as mean +− S.E.M. Statistically significant
differences were calculated using the two-tailed unpaired t test or
one-way ANOVA with a P-value of0.05 considered significant.
Statistical analyses were performed using Prism 5.0 (GraphPad
Software).
RESULTS
This study had two main objectives, the first to determine the
influence of oxygen tension on the cytotoxicity of the NO• donor
DETA/NO and the subsequent reactive intermediates responsible
for this toxicity. The second aim was to investigate the molecu-
lar mechanism responsible for NO•-induced cytotoxicity under
hypoxic conditions.
DETA/NO cytotoxic effects were enhanced under
hypoxia
Decomposition of DETA/NO in solution involves the release of
NO• (2 mol) and the originally reacted nucleophile (1 mol). In or-
der to establish that the observed cytotoxic effects of DETA/NO
were not due to the donor carrying moiety, we tested the cytotoxic
effects of the DETA/NO carrier molecule (diethylenetriamine)
in MDA-MB-231 cells. Different concentrations of DETA/NO
were pre-incubated for 7 days in the cell culture medium at
37 ◦C in order to ensure complete liberation of NO• prior to
treating MDA-MB-231 cells with the spent donor. Cytotoxicity
analysis of the accumulating nucleophile residue of DETA/NO
showed no decrease in cell survival compared with the untreated
controls (Figure 1A); therefore we concluded that the DETA/NO
carrier molecule was inert in our studies. The cytotoxicity of
the NO• releasing compound DETA/NO was examined in an
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Figure 1 Evaluation of NO•-induced toxicity from DETA/NO
(A) Clonogenic assay showing surviving fraction of MDA-MB-231 cells
after 1 week incubation following treatment with a range of pre-incub-
ated DETA/NO concentrations. DETA/NO was prepared in the DMEM
medium and incubated at 37 ◦C for 7 days to ensure complete lib-
eration of NO• molecules before addition to MDA-MB-231 cells for
immortalized normal (L132) and two human tumour (MDA-
MB-231 and DU145) cell lines under normoxia (21 % O2),
hypoxia (0.1 % O2) and anoxia (95 % N2, 5 % CO2) (Figure 1B).
Our previous results demonstrate that cell survival under mild
hypoxia (1 % O2) is similar to normoxic conditions, and 24 h
exposure of cells to both 1 % O2 and 0.1 % O2 alone did not
significantly affect survival in any of the cell lines (results not
shown). There was variability in the cytotoxic potential of NO•
between tumour cell lines and the normal immortalized cell
line L132, which was significantly more resistant compared
with the two tumour cell lines under similar treatment condi-
tions Exposure to DETA/NO under hypoxia at 0.1 % O2 was
significantly more cytotoxic than in normoxia. The enhancing
effect of hypoxia on DETA/NO-induced cytotoxicity was dose-
modifying, albeit at higher DETA/NO concentrations. Treatment
of cells with DETA/NO under anoxia produced significantly
less cytotoxicity compared with 0.1 % hypoxia and normoxia
(Figure 1B).
ONOO− , HNO and NO2 −/NO3 − formation are not
prerequisites for DETA/NO cytotoxicity
In an attempt to determine the contribution made by toxic react-
ive intermediates of DETA/NO in cytotoxicity, we used specific
scavengers of ONOO− (Ebselen, Apocynin and FeTPPs) in com-
bination with the DETA/NO treatment. Each of these scavengers
has a different mechanism to eliminate ONOO− formed fol-
lowing NO• exposure and is proven to protect against ONOO−
cytotoxic effects [24–26]. Pre-treatment of MDA-MB-231 cells
with the scavengers before treatment with DETA/NO for 24 h
under 21 % O2 and 0.1 % O2 showed no significant difference in
cell survival under normoxic or hypoxic conditions (Figure 2).
The efficacy of TEMPO-9-AC as a probe for HNO was shown
using different doses of AS. However, addition of the LD50 values
of DETA/NO to MDA-MB-231, DU145 and L132 cells for 24 h
left the TEMPO-9-AC fluorescence intensity unaffected both at
normoxia and 0.1 % hypoxia (Figure 3A), indicating that HNO
was not produced following the treatment with DETA/NO. Res-
ults also revealed that NO2 − and NO3 − are not the cytotoxic
species following the treatment with DETA/NO (Figure 3B).
the duration of the assay (24 h). (B) Clonogenic assays to determ-
ine the effect of DETA/NO concentration on cell survival under nor-
moxia, and 0.1 % O2. MDA-MB-231, DU145 and L132 cells were in-
cubated under either normoxic or hypoxic [21 % (v/v) O2 or 0.1 % (v/v)
O2, 0 % (v/v) O2] conditions for 24 h at 37 ◦C prior to the 24 h treat-
ment with DETA/NO. Fresh medium was placed on the cells, which were
then incubated for 2 weeks and then stained with 0.4 % crystal violet
for colony counts. Data are the means of three independent experi-
ments +− S.E.M. Statistical significance was calculated using a one-way
ANOVA. Exposure to DETA/NO under hypoxia at 0.1 % (v/v) O2 was signi-
ficantly more cytotoxic than in normoxia (P= 0.0084, 0.0317, 0.0074,
for MDA-MB-231, DU145 and L132 cells, respectively). Treatment of
cells with DETA/NO under anoxia produced significantly less cytotox-
icity compared with 0.1 % hypoxia and normoxia (P= 0.0045, 0.008,
0.046 under anoxia compared with normoxia for MDA-MB-231, DU145,
and L132 cells, respectively; P= 0.004, 0.0001, 0.001 under anoxia
compared with 0.1 % hypoxia for MDA-MB-231, DU145 and L132 cells,
respectively, using one-way ANOVA test).
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Figure 2 Clonogenic assay to determine the effects of the ONOO− scavengers Ebselen (EB 10 μM), FeTPPs (50 μM) and
Apocynin (APO 300 μM) on cell survival following the treatment with DETA/NO under normoxia and 0.1% (v/v)
O2
MDA-MB-231 cells were incubated under either normoxic or hypoxic [21 % (v/v) O2 or 0.1 % (v/v) O2] conditions for 24 h
at 37 ◦C. ONOO− scavengers were added to the cells 2 h prior to the 24 h treatment with DETA/NO. Fresh medium was
placed on the cells, which were then incubated for 2 weeks and then stained with 0.4 % crystal violet for colony counts.
Data are the means of three independent experiments +− S.E.M. Statistical significance was calculated using a one-way
ANOVA.
Contribution of N2O3 to DETA/NO cytotoxicity
DAF-2DA was used to assess nitrosylation potential of N2O3
because N2O3 rather than NO• nitrosylates DAF-2 to DAF-2
triazole [27] which can be measured by fluorescence. DAF-2DA
does not react with NO2 − , NO3 − or other RNS such as HNO or
ONOO− which confers an element of specificity [28]. Our evalu-
ation of DAF-2 against those species confirmed the finding of the
previously mentioned study (Supplementary Figure S2 available
at http://www.bioscirep.org/bsr/033/bsr033e031add.htm). DAF-
2 triazole metabolite increased approx. 24-fold (depending on
the cell type) under normoxia (Figure 4A). Although the reac-
tion of NO• was slower under hypoxia than in the case of nor-
moxia because of the lack of O2 as a reactant, DAF-2 triazole
was comparable under hypoxia following a 24 h incubation of
1 mM DETA/NO, resulting in an approximate 23-fold increase
over control levels. This result was further confirmed by ana-
lysis of DAF-2 triazole fluorescent product in the presence of the
N2O3 scavengers ascorbate, GSH and sodium azide. This res-
ulted in equal abrogation of DAF-triazole formation under both
oxygen concentrations (Figure 4B). Clonogenic survival studies
using N2O3 scavengers clearly demonstrated that N2O3 contrib-
uted towards NO•-mediated cytotoxicity evidenced by the rescue
of clonogenicity (Figure 5). GSH and ascorbate were previously
shown to scavenge N2O3 derived from IFN-γ (interferon γ ),
LPS (lipopolysaccharide)-stimulated ANA-1 macrophages [28]
and sodium azide, a known NO+ acceptor that has been shown
to be a more specific scavenger for N2O3 [29].
RSNO formation following DETA/NO treatment
Protein S-nitrosylation was investigated using the biotin
switch assay, which was validated in our study (Supplement-
ary Figure S3 available at http://www.bioscirep.org/bsr/033/
bsr033e031add.htm). This study is the first in vitro study that
shows significant RSNO formation in cancer cells exposed to
high NO• levels under hypoxia. Exposure of MDA-MB-231 cells
to either HNO or ONOO− did not result in the formation of
RSNO compared with controls. However, S-nitrosothiol form-
ation increased following the treatment with DETA/NO (Fig-
ures 1 and 6). Pre-treatment of MDA-MB-231 cells with the
N2O3 scavenger sodium azide followed by DETA/NO for 24 h
under both oxygen conditions ablated the previous increase in S-
nitrosothiol formation (Figures 2 and 6), which further supports
the involvement of N2O3 in S-nitrosylation. Evidence from the
nuclear extracts also revealed that S-nitrosylation occurs in
the nucleus (Figures 3 and 6).
Quantification of GSH levels under 21% O2 and
0.1% O2
Results revealed that cells contain high GSH levels ranging
between 5 and 6 mM dependent on cell type, and a slight de-
crease in GSH levels under 0.1 % hypoxia occurred only after
24 h (Figure 7, line graphs). Addition of the LD50 values of
DETA/NO showed a significant decline in GSH levels, which
were time-dependent. A greater GSH reduction was evident in
0.1 % hypoxia compared with normoxia in the three tested cell
lines (Figure 7, bar graphs).
DETA/NO induces greater apoptosis under hypoxia;
involvement of both apoptotic pathways
In order to establish whether the increased DETA/NO-induced
cytotoxicity at low oxygen tensions was a result of the intrinsic
or extrinsic apoptotic pathway, the levels of key apoptotic pro-
teins were analysed. The results indicate that DETA/NO-induced
apoptosis was via both the internal and external pathways. Con-
tribution of extrinsic apoptosis was confirmed by caspase 8 ac-
tivation and Fas receptor up-regulation, which was more obvious
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Figure 3 Contribution of nitroxyl, nitrite and nitrate towards NO•-mediated cytotoxicity
(A) TEMPO-9-AC was used to detect HNO following cellular exposure to DETA/NO. MDA-MB-231, DU145 and L132 cells
were treated with LD50 concentrations of DETA/NO for 24 h under normoxic or 0.1 % hypoxic conditions and the response
compared with AS (10 μM–1 mM). Fluorescence was measured using a fluorescence plate reader with an excitation
wavelength of 361 nm and a detection wavelength of 430 nm. Data were plotted as fold induction of TEMPO-9-AC-H
relative to the controls. Data are the means of four independent experiments +− S.E.M. (B) Clonogenic assays to determine
the effect of NO2 − \ NO3 − on cellular survival under normoxia, and 0.1 % (v/v) O2. Cells were incubated under either
normoxic or 0.1 % hypoxic conditions with different doses of NaNO2 and NaNO3 for 24 h at 37 ◦C. Fresh medium was then
placed on the cells, which were then incubated for 2 weeks and then stained with 0.4 % crystal violet for colony counts.
Data are the results of three independent experiments.
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Figure 4 Measurement of N2O3 production from DETA/NO using a DAF-2DA probe
(A) Different DETA/NO concentrations (10 μM–1 mM) were exposed to MDA-MB-231, DU145 and L132 cells loaded
with DAF-2DA probe under normoxia and 0.1 % (v/v) O2. Fluorescence was measured using a fluorescence plate reader
with an excitation wavelength of 485 nm and a detection wavelength of 530 nm. Data were plotted as fold induction of
DAF-2 triazole relative to the controls. Data are the means of four independent experiments +− S.E.M. (B) Quantification
of N2O3 formation using DAF-2DA following the treatment of MDA-MB-231, DU145 and L132 cells with DETA/NO +− N2O3
scavengers ascorbic acid (AA;1 mM), L-GSH reduced (GSH; 1 mM) and sodium azide (AZ;1 mM) under normoxia or 0.1 %
hypoxia. Data were plotted as fold induction of DAF-2 triazole fluorescence relative to the controls. Data are the means
of three independent experiments +− S.E.M. The asterisk indicates the significant difference in DAF-2 triazole fluorescence
with DETA/NO +− N2O3 scavengers compared with DETA/NO (*P0.05, **P0.005, ***P0.0005 using a two-tailed
unpaired t test).
under 0.1 % hypoxia compared witho normoxia (Figure 8). The
three cell lines tested (Figures 9A–9C, and Supplementary Fig-
ure S4 at http://www.bioscirep.org/bsr/033/bsr033e031add.htm)
showed the increased expression of the active forms of both the
initiator caspase 9 and effector caspase 3 in a time-dependent
manner and cleavage of PARP, an enzyme that is critical in cellu-
lar processes such as the repair of potentially lethal DNA damage.
Cleavage of PARP has also been shown to be more signific-
ant under 0.1 % O2 compared with 21 % O2. Under normoxic
conditions, only slight S-nitrosylation of caspases 9 and 3 was
observed.
DETA/NO treatment destabilizes HIF-1α and
increases nuclear p53 and GAPDH protein
expression
In order to establish the signalling pathway responsible for the
increase in apoptosis and cytotoxicity mediated by DETA/NO
under hypoxia, we measured nuclear levels of the hypoxia-
regulated protein HIF-1α, p53 and GAPDH post-treatment with
LD50 concentrations of DETA/NO at 8, 18 and 24 h under
normoxia or 0.1 % (v/v) O2 in MDA-MB-231, DU145 and
L132 cells (Figures 10A–10C, and Supplementary Figure S5
at http://www.bioscirep.org/bsr/033/bsr033e031add.htm). Treat-
ment of cells with DETA/NO resulted in significant HIF-1α ac-
cumulation compared with untreated cells at 21 % O2, whereas
treatment of cells with DETA/NO under 0.1 % hypoxia signific-
antly abrogated the hypoxia-mediated increase in HIF-1α. Fol-
lowing the treatment with LD50 concentrations of DETA/NO,
accumulation of nuclear p53 increased with time under both 21
and 0.1 % (v/v) O2 relative to untreated controls with the highest
fold induction of p53 observed under 0.1 % O2. Further invest-
igation of key proteins for S-nitrosylation revealed that nuclear
GAPDH was also S-nitrosylated.
DISCUSSION
Studies of NO• cytotoxicity under normoxia suggest that the
presence of O2 is a basic requirement for NO• toxicity. Stewart
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Figure 5 Dose–response curves showing survival of MDA-MB-231, DU145 and L132 cells following the exposure to vari-
ous concentrations of DETA/NO, under both normoxic or 0.1% hypoxic conditions+−N2O3 scavengers ascorbic
acid (AA; 1 mM), L-GSH reduced (GSH; 1 mM) and sodium azide (AZ; 1 mM)
Data are the mean of three independent experiments +− S.E.M. Statistical significance was calculated using a one-way
ANOVA [P= 0.003, 0.044, 0.0001 for MDA-MB-231, DU145 and L132 cells, respectively, treated with DETA/NO +− sodium
azide under 21 % (v/v) O2 compared with DETA/NO treatments; P= 0.0001 for MDA-MB-231, DU145 and L132 cells
treated with DETA/NO +− sodium azide under 0.1 % (v/v) O2 compared with the DETA/NO treatments].
et al. [30] demonstrated resistance of PC-3 cells to cytotoxicity
following treatment with the NO• donor NO-sulindac under low
oxygen tensions [30]. Although most in vitro studies to date are
focused on the radiosensitization or chemosensitization effect of
hypoxic tumour cells by NO•, only very few studies postulate
that the addition of NO• under hypoxia could have a synergistic
effect [31,32] and only one study demonstrated this effect on a
cancerous cell line (human fibrosarcoma cells) [32]. However,
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Figure 6 Biotin switch assay to determine the extent of protein S-nitrosylation following exposure to NO• and ONOO−
RSNO profile in MDA-MB-231 cells following the treatment with ONOO− (1 mM), AS (1 mM), or LD50 concentrations of
DETA/NO under normoxia or 0.1 % hypoxia (*), (2) or MDA-MB-231 cells treated with DETA/NO +− sodium azide. (3) The
S-nitrosylated total protein profile in nuclear extracts following the treatment with LD50 concentrations of DETA/NO. Whole
cell or nuclear lysates were subjected to the biotin switch method, biotin labelled nitrosoproteins were separated on
SDS/PAGE (10 % gel) and detected by Western blot analysis with an anti-biotin antibody. In parallel, β -actin or H2B protein
levels served as a loading control. Images shown are the representative blots of three independent experiments. Arrows
on the left point to visible bands representing the molecular mass of S-nitrosylated proteins.
the precise mechanisms by which the hypoxia conferred NO•-
induced cytotoxicity have not been elucidated. The results from
this paper indicate that 0.1 % hypoxia showed the greatest en-
hancement of DETA/NO cytotoxic effects. However, L132 cells
were rather resistant compared with MDA-MB-231 and DU145
cells, which could be attributed to a higher free-radical scaven-
ging capacity of those cells (GSH levels were slightly higher
in L132 cells compared with MDA-MB-231 and DU145 cells).
McMurtry et al. [33] recently demonstrated that the NO• donor
drug JS-K decreased the viability of breast cancer cell lines, but
hardly affected the viability of normal mammary epithelial cells
(HMEC-1). It was suggested in the study that higher expression
of cellular defence enzymes by normal cells might protect against
NO•-mediated cytotoxicity more than malignant cells, thus es-
tablishing selective cytotoxicity against malignant cells [33]. It
is possible that GSH depletion particularly under 0.1 % hypoxia
renders cells more vulnerable to the cytotoxic effects of NO•
in this study, which could be explained as a result of increased
production of ROS (reactive oxygen species), or impaired GSH
synthesis under hypoxia.
DETA/NO cytotoxicity was attributed to NO•-related reactive
species rather than the direct cytotoxic effect of NO•, as cell
survival increased whenever the source of O2 was withdrawn
(anoxia). This result indicates the requirement of either O2 or
(O2• − ), for the formation of secondary oxidative species of NO•
(Supplementary Scheme S1 Reactions 1–3).
Despite many studies implicating ONOO− as a key mediator
of cell death following NO• exposure [34,35], these findings
indicate that ONOO− is not a reactive intermediate in high NO•
generating therapies. Furthermore, NO• reduction to HNO will
not occur by simple electron transfer because of the low reduction
potential of NO•, which has previously been determined to be
approx. − 0.5 V at pH 7 [36]. Consistently, our results indicate
the absence of HNO with DETA/NO treatment, further evidenced
by the lack of TEMPO-9-AC fluorescent metabolite following the
treatment with DETA/NO. In addition, both NO2 − and NO3 −
on their own did not show any particular cytotoxic effects in cells
treated with NaNO2 and NaNO3 salts, therefore it is unlikely that
NO2 − and NO3 − are the cytotoxic species following DETA/NO
treatment.
As ONOO− formation requires both NO• and (O2• − ), each of
the reactants are produced at variable rates, which are dependent
on environmental conditions. Therefore it is possible that the ex-
cess reactant could participate in further reactions. For example
when (O2• − ), is generated in excess of NO•, the formation of
O2NOO− (peroxynitrate) (Supplementary Scheme S1 Reaction
5) is likely to be produced from the reaction of (O2 − ), with •NO2.
Other possibilities arise when NO• is generated up to three times
faster than (O2 − ), NO• reacts with •NO2 to form N2O3, which
reacts quickly with any existing ONOO− to produce NO2 −
and two further molecules of •NO2 (Supplementary Scheme S1
Reaction 6). These •NO2 molecules can then further react with the
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Figure 7 NO• suppression of glutathione
MDA-MB-231, DU145 and L132 cells were incubated under normoxia
or 0.1 % hypoxia for 2–24 h (line graphs) or treated with LD50 values of
DETA/NO for 1–24 h at either normoxia or 0.1 % hypoxia (bar graphs)
and GSH content was determined using an optimized enzymatic recyc-
ling method that uses GR for GSH quantification. All data were normal-
ized to mg protein, and DETA/NO bar graphs were expressed as fold
induction of GSH/mg protein relative to controls. Data are the mean of
four independent experiments +− S.E.M.
excess NO• (for example, from a NO• donor drug) to
form the potent nitrosating agent N2O3 facilitating further
toxicity [37].
O2 − is produced as a product of mitochondrial respiration due
to the action of NOX (NADPH oxidase). Under normal conditions
it is scavenged by SOD (superoxide dismutase); however, under
hypoxic conditions particularly in tumours, O2 − levels remain
high because of the reduction in the scavenger SOD and the
fact that NOX levels are elevated under these conditions [38].
This ensures that when CO2 levels are elevated, the cytotoxic
species N2O3 can be produced following DETA/NO treatment
[18] (Supplementary Scheme S1 Reaction 7).
The results clearly suggest that the reactive intermediate
N2O3 is responsible for the NO•-mediated toxicity at both low
and high oxygen tensions. Although the precise mechanism of
S-nitrosylation in cells is not well understood, the favoured reac-
tion pathway for S-nitrosylation is produced from the reaction of
N2O3 with a thiol (Supplementary Scheme S1 Reaction 4). This
reaction becomes of greater relevance for S-nitrosothiol forma-
tion at higher NO• concentrations [18] since the latter are directly
linked to the local N2O3 concentration in cells.
An elegant kinetic study by Lancaster [39] using GSH as a
thiol model showed significant generation of RSNO with NO•
concentrations exceeding 22.8 μM [39], which fits well with this
study’s estimation of NO• liberation from DETA/NO. Our find-
ing revealed that after 24 h of DETA/NO treatment at LD50 con-
centrations, approx. 25 μM NO• were liberated as evidenced by
accumulation of NO2 − and NO3 − levels. Further analysis of
the fate of NO• liberated from DETA/NO can be elucidated by
comparing the ratio of NO2 − (marker of nitrosylation) to NO3 −
(marker of oxidation), which revealed higher NO2 − to NO3 −
(12 NO2 − : 1 NO3 − ) (Supplementary Figure S1). This is typical
of N2O3-dependent S-nitrosylation.
Qualitative determination of RSNO revealed that a number of
proteins were S-nitrosylated only when DETA/NO was added
to cells. Some studies suggest that RSNO may be formed from
ONOO− ; however, <1 % of ONOO− was shown to produce
RSNO in vitro [40]. Furthermore, relatively very few studies
mention the formation of RSNO in an anaerobic environment
[41,42], with all focusing on NOS-induced NO•. These studies
indicate that the NO•-induced S-nitrosylation is abrogated in the
presence of sodium azide. Therefore it can be concluded that the
effect with DETA/NO is independent of either HNO or ONOO−
and linked to N2O3 formation under both oxygen tensions.
Possible mechanisms of cytotoxicity
Examining the kinetics of both apoptotic pathways following
DETA/NO exposure revealed induction of both the intrinsic and
extrinsic apoptotic pathways. Activation of both initiator caspase
9 and effector caspase 3 were evident at earlier time points under
0.1 % (v/v) O2, which indicates that the coupled effect of hypoxia
and DETA/NO induced earlier apoptosis. PARP is an important
enzyme involved in cellular processes such as cell death and
DNA repair. Cleavage of PARP is associated with inactivation
and apoptosis and has also been shown to correlate with caspase
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Figure 8 Up-regulation of extrinsic apoptotic pathways following treatment with DETA/NO
(A) Caspase 8 activity was measured in MDA-MB-231, DU145 and L132 cells following treatment with LD50 values of
DETA/NO for 24 h either at normoxia or 0.1 % hypoxia using a fluorigenic substrate AFC as an indicator for caspase 8 activity.
Data were plotted as fold induction of AFC fluorescence relative to controls. Data are the means of three independent
experiments +− S.E.M. (B) Detection of Fas receptor expression following the treatment of MDA-MB-231, DU145 and L132
cells with LD50 concentrations of DETA/NO. Data were plotted as fold change in Fas expression normalized to controls
over a time course for both 21 % O2 normoxia (N) and 0.1 % O2 hypoxic conditions (H). Representative Western blots and
the mean densitometric values +− S.E.M. for three independent experiments are shown.
3 activation [43]. Cleavage of PARP was obvious in our results
and again was present earlier when cells were exposed to both
DETA/NO and 0.1 % O2. The present study concurs with previous
reports [44] detailing the involvement of the intrinsic pathway of
apoptosis following NO• treatments. The potential implication of
the extrinsic pathway of apoptosis was also evidenced by higher
Fas expression levels and an increase in caspase 8 activity after
24 h DETA/NO treatment. This effect was also more obvious un-
der 0.1 % hypoxia compared with normoxia, suggesting that the
cellular stress induced by both DETA/NO and hypoxia aug-
mented this pathway of apoptosis. The role of NO• in
Fas mediated apoptosis is still controversial with various
studies confirming its role [45] and others disproving it
[46]. Only recently Leon et al. [47] demonstrated that the
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Figure 9 Evidence of activation of intrinsic apoptotic proteins following treatment with DETA/NO
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Figure 10 Western blot analysis of nuclear proteins (HIF-1α, p53 and GAPDH) expression over time under both normoxia
and 0.1% O2 hypoxia
(A) MDA-MB-231, (B) DU145 and (C) L132 cells. Both S-nitrosylated and total proteins were examined as previously
mentioned in Figure 9. Data were the mean densitometric values +− S.E.M. for three independent experiments and was
plotted as fold change in protein expression normalized to controls over a time course of both 21 % (v/v) O2 normoxia and
0.1 % (v/v) O2 hypoxia.
sensitization of cancer cells to Fas ligand induced apoptosis oc-
curred after NO•-induced S-nitrosylation of cysteine residues
in the cytoplasmic part of Fas receptor [47]. DETA/NO-
induced apoptosis was first observed after 8 h with more
pronounced effects by 24 h. This is a similar trend to the
S-nitrosylation results which are in agreement with Duan and
Chen [48] who detected increasing amounts of the total RSNO in
cells undergoing apoptosis [48]. Conversely, it has been shown
previously that S-nitrosylation of caspases prevents their activity
and suppresses apoptosis [49]. This effect was observed in our
study in untreated cells (a normal mechanism of pro-caspase
existence in cells); however, the treatment with DETA/NO
completely abrogated this effect. Therefore it is likely that the
treatment with DETA/NO and the subsequent production of N2O3
up-regulates Fas expression known to denitrosylate caspases en-
abling apoptotic cleavage [50].
Caspase 9 and 3 (total and S-nitrosylated) and PARP cleavage over a time course following the treatment of MDA-MB-231 (A), DU145 (B) and L132
(C) cells with LD50 concentrations of DETA/NO under both normoxia and 0.1 % (v/v) O2 hypoxia. Data are the mean densitometric values +− S.E.M.
for three independent experiments and are plotted as fold change in protein expression normalized to controls over a time course of both 21 % O2
normoxia and 0.1 % (v/v) O2 hypoxia. The asterisk indicates significant difference under 0.1 % (v/v) O2 hypoxia compared with normoxia for the total
protein (*P0.05, **P0.005, ***P0.0005 using a two-tailed an unpaired t test).
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Inhibition of the adaptive cellular response during hypoxia
compared with normoxia as shown by destabilized HIF-1α
transcription following the treatment with DETA/NO renders
the cells more susceptible to NO• cytotoxicity. Previous stud-
ies have found that NO• destabilizes HIF-1α [51]. This could
account for another mechanism of NO• cytotoxicity under hyp-
oxia, where our data revealed that HIF-1α up-regulation was
through S-nitrosylation. Furthermore, a significant increase in
p53 observed over time under 0.1 % hypoxia compared with nor-
moxia was consistent with other reports detailing that exposure
to severe hypoxia (0.2 % O2) leads to p53 accumulation, and el-
evated apoptosis [52]. It was previously demonstrated that p53
is implicated in the degradation of HIF-1α [53]; therefore we
speculate that overexpression of p53 under hypoxia may ac-
count for the loss of HIF-1α levels, which consequently pro-
motes the induction of apoptosis under hypoxia compared with
normoxia. Results in this study showed that p53 itself is a tar-
get for S-nitrosylation, which suggests that S-nitrosylation of
p53 is essential for its activity towards induction of its down-
stream effectors of apoptosis. This observation could potentially
be explained by the ten cysteine residues found in p53, two of
which are particularly reactive (Cys182 and Cys277) [54]. How-
ever, it was recently reported that S-nitrosylation of p53 shows
an inhibitory effect because of alteration in DNA binding [55],
this represents the only study that detects S-nitrosylated p53,
and clearly it remains to be experimentally confirmed whether
S-nitrosylation of p53 and p53 accumulation contributes to cyto-
toxicity or apoptosis induced by N2O3. Nuclear S-nitrosylated
GAPDH was shown recently to mediate NO•-triggered GAPDH
apoptosis [56] and mediated nitrosylation of nuclear proteins,
such as SIRT1 [57]. SIRT1 has been shown to block p53-
induced apoptosis through p53 deacetylation and induction of
manganese SOD [58]. Its inhibition through nitrosylation could
therefore potentiate p53 activity. S-Nitrosylation of GAPDH and
its nuclear accumulation, as well as NOS-dependent apoptosis,
were detected in thyroid carcinoma cells treated with TRAIL
(TNF-related apoptosis-inducing ligand) and has been sugges-
ted that this mechanism contributes to the tumour-selective ef-
fects of TRAIL [59]. This represents the only study that used
cancer cells for this type of investigation. Similar studies in-
vestigating the role of NO• in GAPDH-mediated cell death
used NOS as a source of NO•. This approach could be used
to mimic our donor drug in terms of sustained NO•. However,
cumulative NO• concentrations were very low compared with
the high μM concentrations of NO• produced by DETA/NO,
which suggests that this mechanism takes place to mediate cell
death under higher NO• fluxes associated with hypoxia-induced
stress.
CONCLUSIONS
The data presented provides compelling evidence suggesting that
NO• sensitizes tumour cells to hypoxia, mediated by an apop-
totic mechanism involving down-regulation of HIF1α and that the
cytotoxic intermediate is not ONOO− or HNO but rather N2O3.
The data also highlight an emerging role of S-nitrosylation by
N2O3 as a post-translational modification event that has an im-
portant role in NO•-induced cytotoxicity, and we showed that
p53 itself might be a target for S-nitrosylation following the
treatment with DETA/NO. Furthermore, S-nitrosylated GAPDH
was detected, which may play a key role in DETA/NO-mediated
apoptosis and cytotoxicity. Therefore this study elucidates further
mechanisms of DETA/NO mediated cytotoxicity with respect to
S-nitrosylation. This could shed the light on the diverse role and
molecular mechanisms of NO•, which play a part in enhanced
cytotoxicity under hypoxia, an effect that could be specifically
targeted for therapeutic benefit.
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Figure S1 The levels of NO• in culture medium were indirectly determined using ion-selective electrodes to independ-
ently measure NO2 − and NO3 − at specific time points
MDA-MB-231, DU145 and L132 cells were incubated with 0.1 mM DETA/NO over time under 21 % (v/v) O2 and 0.1 %
(v/v) O2 and reading was taken at specific time points. Data are the means of three independent experiments +−S.E.M.
displayed as separate NO2 − and NO3 − readings. Total NO2 − and NO3 − were comparable under normoxia and hypoxia for
the same dose, while comparing the ratio of NO2 − (marker of nitrosylation since all nitrosating intermediates metalizes to
NO2 − at the end) to NO3 − (marker of oxidation since all oxidative intermediates metalizes to NO3 − at the end) revealed
higher NO2 − to NO3 − (12 NO2 − : 1 NO3 − ).
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Figure S2 DAF-2DA reactivity towards 1 mM of DETA/NO, AS (HNO
donor), ONOO− , NO2 − , or NO3 −
MDA-MB-231, DU145 and L132 cells were loaded with DAF-2DA, treated
with aforementioned RNS for duration in accordance with their half lives,
and fluorescence was measured using fluorescence plate reader with
an λex of 485 nm and a detection wavelength of 530 nm. DAF-2 triazole
fluorescent metabolite was due to N2O3 formed following cellular ex-
posure to DETA/NO; therefore it is indirect measurement of N2O3.
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Figure S3 Representative Western blot of the biotinylation profile in MDA-MB-231 cells following treatment with
DETA/NO
(A) Extracts from untreated or DETA/NO treated MDA-MB-231 cells were subjected to the biotin switch method after
omitting one or two steps of the method. (B) To verify biotin labelling specificity for S-nitrosothiols, both the effects of
omitting ascorbate and biotin in the assay are shown.
Figure S4 Representive Western blots of cytoplasmic extracts of (A) MDA-MB-231, (B) DU145 and (C) L132 cells quan-
tified for total and S-nitrosylated apoptotic proteins via biotin switch assay
Extracts were probed for caspase 9, 3 (total and S-nitrosylated) and PARP cleavage over a time course following the
treatment with LD50 values of DETA/NO under both normoxia and 0.1 % (v/v) O2 hypoxia.
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Figure S5 Representive Western blots of nuclear proteins (HIF-1α, p53 and GAPDH) expression over time following the
treatment with LD50 values of DETA/NO under both normoxia and 0.1% (v/v) O2 hypoxia of (A) MDA-MB-231,
(B) DU145 and (C) L132 cells
Cells were quantified for the total and S-nitrosylated apoptotic proteins via the biotin switch assay.
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Scheme 1 Potential mechanisms for the production of various reactive nitrogen species generated from NO•
Reaction (1): the production of peroxynitrite (ONOO− ). Reaction (2): the production of nitrogen dioxide (NO2•). Reaction
(3): the production of dinitrogen trioxide (N2O3). Reaction (4): the production of nitrosothiols (RSNO). Reaction (5): the
production of peroxynitrate (O2NOO− ). Reaction (6): dinitrogen trioxide and peroxynitrite react to form two molecules of
•NO2. Reaction (7): when CO2 levels are elevated N2O3 can be generated in the presence of DETA/NO.
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